• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    4.72 Up 0.24(5.36%) Feb 12, 4:00PM EST
    |After Hours : 4.72 Up 0.00 (0.02%) Feb 12, 5:07PM EST
    Prev Close:4.48
    Open:4.53
    Bid:N/A
    Ask:4.89 x 200
    1y Target Est:7.88
    Beta:1.64489
    Next Earnings Date:23-Feb-16ARIA Earnings announcement
    Day's Range:4.48 - 4.72
    52wk Range:4.37 - 10.07
    Volume:2,805,885
    Avg Vol (3m):3,506,410
    Market Cap:893.46M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 5.36%893.46M
    PFEUp 0.79%181.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.24
    Quarterly EPS Est (Dec-15) :-0.31
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback